Transplantation of Autologous Peripheral Blood Mononuclear Cells for Amyotrophic Lateral Sclerosis

Completed 14 enrolled The First Affiliated Hospital of Dalian Medical University

NaSingle-groupOpen-labelTreatment

Summary

To assess the safety of peripheral blood mononuclear cell transplantation into the subarachnoid space for the treatment of amyotrophic lateral sclerosis.

Timeline

Start: 2010-10
Primary completion: 2012-12
Completion: 2013-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	PBMC autotransplantation	Unknown	—	Intrathecal

Transplantation of Autologous Peripheral Blood Mononuclear Cells for Amyotrophic Lateral Sclerosis

Summary

Timeline

Drugs

Indications